Molecular Imaging in Multiple Myeloma (Record no. 29092)

MARC details
000 -LEADER
fixed length control field 02157nam a22002657a 4500
001 - CONTROL NUMBER
control field 20241009114933.0
003 - CONTROL NUMBER IDENTIFIER
control field 20241009114933.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241009115747.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241009b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-030-19018-7
International Standard Book Number 978-3-030-19019-4
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994 18 NAN
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Cristina Nanni
245 ## - TITLE STATEMENT
Title Molecular Imaging in Multiple Myeloma
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Springer Nature Switzerland AG |
Date of publication, distribution, etc. 2019
Place of publication, distribution, etc. Policlinico S.Orsola-Malpighi Bologna Italy |
300 ## - PHYSICAL DESCRIPTION
Extent 138 Pages
520 ## - SUMMARY, ETC.
Summary, etc. This book provides a comprehensive overview of the importance of molecular imaging in multiple myeloma, with detailed explanation of its clinical impact. Other important features are the definition of criteria that will aid PET/CT interpretation; identification and explanation of the most frequent pitfalls; a brief overview of the advantages and limitations of DWI MR imaging, still an experimental technique in multiple myeloma; and examination of the possible role of emerging PET tracers. When appropriate, clinical cases are used to illustrate key teaching points. All physicians involved in oncological imaging should regularly reassess and update their routine practice in the evaluation of multiple myeloma patients. <br/><br/>This is especially true now, given the recent clarification by the International Myeloma Working Group (IMWG) of the criteria for bone damage requiring therapy and the emerging data supporting the role of the newer functional imaging techniques in predicting outcome and/or evaluating response to therapy. In this challenging context, Molecular Imaging in Multiple Myeloma will be of high value for nuclear medicine physicians, radiologists, and hematologists.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Hematology, Medical / Clinical Medicine, Medical / Hematology, Medical / Oncology / General, Medical / Radiology, Radiotherapy & Nuclear Medicine, Nuclear medicine, Oncology, Multiple myeloma -- Imaging -- Molecular aspects.
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Stefano Fanti
Fuller form of name Lucia Zanoni
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-3-030-19019-4 ">https://doi.org/10.1007/978-3-030-19019-4 </a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Full call number Barcode Date last seen Uniform resource identifier Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 10/09/2024   616.994 18 NAN 20241009114933.0 10/09/2024 https://doi.org/10.1007/978-3-030-19019-4 10/09/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024